Digital Healthcare Takes Major Leap Forward: Evaro and Patchs Team Up to Transform NHS Access for 10 Million Patients

In a significant move toward making healthcare as accessible as online banking, digital health pioneer Evaro today announced its integration with Patchs Health's platform. The partnership will enable over 10 million patients across 1,000 GP practices to access NHS prescription services through a simple, user-friendly digital interface.

This collaboration marks a major milestone in modernizing how patients access NHS Pharmacy First services. Through Patchs' AI-powered platform, patients can now receive treatment for common conditions including urinary tract infections, sore throat, sinusitis, shingles, impetigo and infected insect bites - all without needing to visit a GP or wait for an appointment.

The partnership comes at a crucial time when GP practices are struggling with unprecedented demand. When patients seek treatment through Patchs, they can now choose Evaro's digital service alongside local pharmacy options. Those selecting Evaro complete an AI-supported clinical questionnaire designed by doctors. UK-registered clinicians review each case against NHS guidelines, and if approved, medication is dispatched for next-day delivery at no additional cost.

What makes this integration particularly powerful is Evaro's unique position as one of few digital health providers holding both Care Quality Commission (CQC) registration and an NHS pharmacy licence - allowing them to both prescribe and dispense medication. This dual capability has been essential in enabling seamless integration with major NHS platforms like Patchs.

Dr. Thuria Wenbar, CEO of Evaro commented: "This integration represents a fundamental shift in how healthcare can be delivered at scale. Just as we no longer queue at banks for basic transactions, patients shouldn't need to wait weeks for minor health issues. Our digital-first approach means we can support thousands of NHS patients daily while maintaining rigorous clinical standards - freeing up GP practices to focus on more complex cases. This is about building the future of healthcare, where access is instant but care remains personal."

Marcus Ong, CEO of Patchs added: "By adding Evaro to our carefully selected provider network, we're expanding options for the 10 million patients who rely on Patchs to access healthcare. Their NHS-registered pharmacy service complements our existing providers, particularly for patients who need treatment when their GP practice and local pharmacy are closed or who prefer the convenience of home delivery."

The service will initially cover conditions aligned with the NHS Pharmacy First scheme, with plans to expand as the NHS adds more conditions to the program. This partnership represents another step toward Evaro's vision of making healthcare access as seamless as modern banking - where routine health needs can be addressed quickly and safely through digital channels, while maintaining the high standards of NHS care.

About Evaro

Evaro is a UK-based startup making access to minor healthcare faster, convenient and affordable. Founded by medical professionals Dr. Thuria Wenbar and Dr Oskar Wenbar, Evaro provides NHS and private prescription services through asynchronous consultations reviewed by UK-registered clinicians. The company holds both General Pharmaceutical Council and Care Quality Commission registration, operating its own NHS-registered pharmacy warehouse. Having supported 600,000 patients to date, Evaro aims to help 10 million people access faster treatment for minor health conditions.

About Patchs 

Patchs Health Hub connects over 10 million patients to healthcare services through GP practices. The company uses AI technology to streamline patient access to NHS services, support groups and health information. Patchs simplifies healthcare journeys by combining content, advice and carefully selected healthcare providers in one platform.